niacinamide has been researched along with transforming growth factor alpha in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cveklova, K; Fausto, N; Merlino, G; Mosinger, B; Wu, JC | 1 |
| Mitaka, T; Mochizuki, Y; Nakamura, T; Norioka, K | 1 |
| Block, GD; Bowen, WC; Howard, TA; Katyal, S; Locker, J; Michalopoulos, GK; Petersen, BE; Riley, T; Strom, SC | 1 |
| Gollob, JA | 1 |
| Dong, X; He, C; Jiang, H; Jiang, X; Ma, L; Pan, S; Qiao, H; Sun, X; Tan, G; Wei, Z; Zhai, B; Zhao, D | 1 |
| Izumi, N; Joko, K; Nishijima, N; Nishio, K; Orito, E; Osaki, Y; Sakai, K; Takeda, H; Uchida, Y | 1 |
1 review(s) available for niacinamide and transforming growth factor alpha
| Article | Year |
|---|---|
Sorafenib: scientific rationales for single-agent and combination therapy in clear-cell renal cell carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; ErbB Receptors; Humans; Kidney Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyridines; Signal Transduction; Sorafenib; Transforming Growth Factor alpha; Vascular Endothelial Growth Factor A; Von Hippel-Lindau Tumor Suppressor Protein | 2005 |
5 other study(ies) available for niacinamide and transforming growth factor alpha
| Article | Year |
|---|---|
Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Topics: alpha-Fetoproteins; Animals; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cell Transformation, Neoplastic; Culture Media, Serum-Free; DNA Replication; Epidermal Growth Factor; Insulin-Like Growth Factor II; Liver; Male; Mice; Mice, Nude; Mice, Transgenic; Niacinamide; Ploidies; RNA, Messenger; Time Factors; Transforming Growth Factor alpha | 1994 |
Effects of mitogens and co-mitogens on the formation of small-cell colonies in primary cultures of rat hepatocytes.
Topics: Animals; Cell Division; Cells, Cultured; Epidermal Growth Factor; Fibroblast Growth Factors; Hepatocyte Growth Factor; Immunohistochemistry; Liver; Male; Mitogens; Niacinamide; Rats; Rats, Sprague-Dawley; Transforming Growth Factor alpha | 1993 |
Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium.
Topics: Adult; Base Sequence; Biomarkers; Cell Differentiation; Cell Division; Cell Lineage; Cells, Cultured; Collagen; Culture Media, Serum-Free; Drug Combinations; Epidermal Growth Factor; Gene Expression Regulation; Hepatocyte Growth Factor; Humans; Keratins; Laminin; Liver; Molecular Sequence Data; Morphogenesis; Niacinamide; Phenotype; Proteoglycans; Proto-Oncogene Proteins c-met; Receptor Protein-Tyrosine Kinases; Transcription Factors; Transferrin; Transforming Growth Factor alpha | 1996 |
Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Agents; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Niacinamide; Phenylurea Compounds; Quinazolines; Signal Transduction; Sorafenib; Transforming Growth Factor alpha; Up-Regulation | 2014 |
Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; beta Catenin; Biomarkers; Biomarkers, Tumor; Biopsy, Fine-Needle; Carcinoma, Hepatocellular; Female; Formaldehyde; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Liver Neoplasms; Male; Middle Aged; Mutation; Neuregulin-1; Niacinamide; Paraffin Embedding; Phenylurea Compounds; Platelet Endothelial Cell Adhesion Molecule-1; Sequence Analysis, DNA; Sequence Analysis, RNA; Sorafenib; Transforming Growth Factor alpha; Treatment Outcome; Tumor Suppressor Protein p53 | 2015 |